TY - JOUR A1 - Preuß, Franziska Friederike A1 - Chatterjee, Deep A1 - Mathea, Sebastian A1 - Shrestha, Safal A1 - St-Germain, Jonathan A1 - Saha, Manipa A1 - Kannan, Natarajan A1 - Raught, Brian A1 - Rottapel, Robert A1 - Knapp, Stefan T1 - Nucleotide binding, evolutionary insights, and interaction partners of the pseudokinase Unc-51-like kinase 4 T2 - Structure N2 - Unc-51-like kinase 4 (ULK4) is a pseudokinase that has been linked to the development of several diseases. Even though sequence motifs required for ATP binding in kinases are lacking, ULK4 still tightly binds ATP and the presence of the co-factor is required for structural stability of ULK4. Here, we present a high-resolution structure of a ULK4-ATPγS complex revealing a highly unusual ATP binding mode in which the lack of the canonical VAIK motif lysine is compensated by K39, located N-terminal to αC. Evolutionary analysis suggests that degradation of active site motifs in metazoan ULK4 has co-occurred with an ULK4-specific activation loop, which stabilizes the C helix. In addition, cellular interaction studies using BioID and biochemical validation data revealed high confidence interactors of the pseudokinase and armadillo repeat domains. Many of the identified ULK4 interaction partners were centrosomal and tubulin-associated proteins and several active kinases suggesting interesting regulatory roles for ULK4. KW - Unc-51-like kinase KW - ULK4 KW - pseudokinase KW - evolution KW - BioID KW - ATP binding KW - interaction partners Y1 - 2020 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/62553 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-625537 UR - https://www.sgc-frankfurt.de/pdfs/Others/Preuss_etal_2020_Nucelotide_Binding_aam2.pdf N1 - Erschienen in: Franziska Preuss et al. (2020): Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4. Structure, 28, 1184–1196.e6. https://doi.org/10.1016/j.str.2020.07.016 VL - 28 IS - 11 SP - 1184 EP - 1196.e6 PB - Elsevier Science CY - London [u.a.] ER -